The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
A correction to this article has been published: Yawata et al., J. Exp. Med. 203 (4) 1131
Published online 13 March 2006 doi:10.1084/jem.20051884
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 3, 633-645
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2801K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Correction (v203,p1131)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yawata, M.
Right arrow Articles by Parham, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yawata, M.
Right arrow Articles by Parham, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

 Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

Makoto Yawata1, Nobuyo Yawata1, Monia Draghi1, Ann-Margaret Little2,3, Fotini Partheniou2, and Peter Parham1

1 Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA 94305
2 Histocompatibility Laboratories, The Anthony Nolan Trust and 3 Department of Haematology, The Royal Free Hospital, London, NW3 2QG, England, UK

CORRESPONDENCE Peter Parham: peropa{at}stanford.edu OR Makoto Yawata: myawata{at}stanford.edu

Interactions between killer cell immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) class I ligands regulate the development and response of human natural killer (NK) cells. Natural selection drove an allele-level group A KIR haplotype and the HLA-C1 ligand to unusually high frequency in the Japanese, who provide a particularly informative population for investigating the mechanisms by which KIR and HLA polymorphism influence NK cell repertoire and function. HLA class I ligands increase the frequencies of NK cells expressing cognate KIR, an effect modified by gene dose, KIR polymorphism, and the presence of other cognate ligand–receptor pairs. The five common Japanese KIR3DLI allotypes have distinguishable inhibitory capacity, frequency of cellular expression, and level of cell surface expression as measured by antibody binding. Although KIR haplotypes encoding 3DL1*001 or 3DL1*005, the strongest inhibitors, have no activating KIR, the dominant haplotype encodes a moderate inhibitor, 3DL1*01502, plus functional forms of the activating receptors 2DL4 and 2DS4. In the population, certain combinations of KIR and HLA class I ligand are overrepresented or underrepresented in women, but not men, and thus influence female fitness and survival. These findings show how KIR–HLA interactions shape the genetic and phenotypic KIR repertoires for both individual humans and the population.

Abbreviations used: KIR, killer cell immunoglobulin-like receptor; LD, linkage disequilibrium; mfi, mean fluorescence intensity.

M. Yawata and N. Yawata contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS